{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:20:03Z","timestamp":1789068003910,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014053","name":"International Research Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jpha.2020.04.008","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T02:47:53Z","timestamp":1588042073000},"page":"320-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":210,"title":["Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase"],"prefix":"10.1016","volume":"10","author":[{"given":"Muhammad Usman","family":"Mirza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus","family":"Froeyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2020.04.008_bib1","series-title":"The 2019-new coronavirus epidemic: Evidence for virus evolution","author":"Benvenuto","year":"2020"},{"key":"10.1016\/j.jpha.2020.04.008_bib2","series-title":"Systematic review of the registered clinical trials of coronavirus diseases 2019 (COVID-19)","author":"Zhu","year":"2020"},{"key":"10.1016\/j.jpha.2020.04.008_bib3","series-title":"Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in\u00a0vitro","author":"Yamamoto","year":"2020"},{"key":"10.1016\/j.jpha.2020.04.008_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in\u00a0vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jpha.2020.04.008_bib5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jpha.2020.04.008_bib6","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in\u00a0vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpha.2020.04.008_bib7","doi-asserted-by":"crossref","first-page":"105932","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"Colson","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jpha.2020.04.008_bib8","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jpha.2020.04.008_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cpt.1857","article-title":"Clinical pharmacology perspectives on the antiviral activity of azithromycin and use in COVID-19","volume":"108","author":"Damle","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.jpha.2020.04.008_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.jpha.2020.04.008_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/v12020135","article-title":"Return of the coronavirus: 2019-nCoV","volume":"12","author":"Gralinski","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jpha.2020.04.008_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/14787210.4.2.291","article-title":"Potential antivirals and antiviral strategies against SARS coronavirus infections","volume":"4","author":"De Clercq","year":"2006","journal-title":"Expert Rev. Anti-infect. Ther."},{"key":"10.1016\/j.jpha.2020.04.008_bib13","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jpha.2020.04.008_bib14","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1085953","article-title":"The genome sequence of the SARS-associated coronavirus","volume":"300","author":"Marra","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jpha.2020.04.008_bib15","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jpha.2020.04.008_bib16","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.79.2.884-895.2005","article-title":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia","volume":"79","author":"Woo","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jpha.2020.04.008_bib17","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1021\/bi0361766","article-title":"Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro","volume":"43","author":"Bacha","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.jpha.2020.04.008_bib18","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1093\/nar\/gkg520","article-title":"SWISS-MODEL: an automated protein homology-modeling server","volume":"31","author":"Schwede","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpha.2020.04.008_bib19","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.jpha.2020.04.008_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"modeling, ZINC\u2212 a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J.\u00a0Chem. Infor."},{"key":"10.1016\/j.jpha.2020.04.008_bib21","doi-asserted-by":"crossref","first-page":"P17","DOI":"10.1186\/1758-2946-4-S1-P17","article-title":"A\u00a0public web service for drug discovery","volume":"4","author":"Kiss","year":"2012","journal-title":"J.\u00a0Cheminf."},{"key":"10.1016\/j.jpha.2020.04.008_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jpha.2020.04.008_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/biom9040124","article-title":"Inhibition of oncogenic kinases: an in\u00a0vitro validated computational approach identified potential multi-target anticancer compounds","volume":"9","author":"Ikram","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpha.2020.04.008_bib24","first-page":"1","article-title":"In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo hemorrhagic fever virus inhibitors","volume":"9","author":"Mirza","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2020.04.008_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jpha.2020.04.008_bib26","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1021\/ci300385h","article-title":"Molecular dynamics investigation on a series of HIV protease inhibitors: assessing the performance of MM-PBSA and MM-GBSA approaches","volume":"52","author":"Srivastava","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jpha.2020.04.008_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.theochem.2006.02.022","article-title":"Investigating interactions between HIV-1 gp41 and inhibitors by molecular dynamics simulation and MM\u2013PBSA\/GBSA calculations","volume":"766","author":"Tan","year":"2006","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.jpha.2020.04.008_bib28","author":"Wu"},{"key":"10.1016\/j.jpha.2020.04.008_bib29","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1529\/biophysj.106.091736","article-title":"Reversible unfolding of the severe acute respiratory syndrome coronavirus main protease in guanidinium chloride","volume":"92","author":"Chang","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.jpha.2020.04.008_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.virusres.2017.01.026","article-title":"Picornaviral polymerase structure, function, and fidelity modulation","volume":"234","author":"Peersen","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.jpha.2020.04.008_bib31","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1002\/j.1460-2075.1989.tb08565.x","article-title":"Identification of four conserved motifs among the RNA-dependent polymerase encoding elements","volume":"8","author":"Poch","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.jpha.2020.04.008_bib32","doi-asserted-by":"crossref","first-page":"22505","DOI":"10.1073\/pnas.1007626107","article-title":"Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase","volume":"107","author":"Gong","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jpha.2020.04.008_bib33","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1093\/nar\/gkt1106","article-title":"RNA-dependent RNA polymerase of Japanese encephalitis virus binds the initiator nucleotide GTP to form a mechanistically important pre-initiation state","volume":"42","author":"Surana","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpha.2020.04.008_bib34","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2147\/DDDT.S75886","article-title":"Pharmacoinformatics approach for investigation of alternative potential hepatitis C virus nonstructural protein 5B inhibitors","volume":"9","author":"Mirza","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jpha.2020.04.008_bib35","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3390\/ijms17111748","article-title":"Integrated computational approach for virtual hit identification against ebola viral proteins VP35 and VP40","volume":"17","author":"Mirza","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2020.04.008_bib36","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2020.04.008_bib37","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/jvi.68.3.1819-1826.1994","article-title":"Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1","volume":"68","author":"Biswas","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jpha.2020.04.008_bib38","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1128\/JVI.74.8.3888-3891.2000","article-title":"Mutation analysis of the GDD sequence motif of a calicivirus RNA-dependent RNA polymerase","volume":"74","author":"V\u00e1zquez","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jpha.2020.04.008_bib39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s11427-011-4216-4","article-title":"Mutational analysis of the SDD sequence motif of a PRRSV RNA-dependent RNA polymerase","volume":"54","author":"Zhou","year":"2011","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.jpha.2020.04.008_bib40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA Polymerase from COVID-19 Virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jpha.2020.04.008_bib41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"Appleby","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jpha.2020.04.008_bib42","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1093\/nar\/gkz409","article-title":"Delicate structural coordination of the severe acute respiratory syndrome coronavirus Nsp13 upon ATP hydrolysis","volume":"47","author":"Jia","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpha.2020.04.008_bib43","doi-asserted-by":"crossref","unstructured":"J. Bajorath, Chemoinformatics and Computational Chemical Biology, Springer, 2011.","DOI":"10.1007\/978-1-60761-839-3"},{"key":"10.1016\/j.jpha.2020.04.008_bib44","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/jmv.25357","article-title":"Perspectives towards antiviral drug discovery against Ebola virus","volume":"91","author":"Mirza","year":"2019","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.jpha.2020.04.008_bib45","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.jpha.2020.04.008_bib46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2008.08.004","article-title":"Molecular targets for flavivirus drug discovery","volume":"81","author":"Sampath","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpha.2020.04.008_bib47","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Liu","year":"2020","journal-title":"Chembiochem"},{"key":"10.1016\/j.jpha.2020.04.008_bib48","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/bi036022q","article-title":"3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism","volume":"43","author":"Huang","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.jpha.2020.04.008_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jmb.2005.09.012","article-title":"pH-dependent conformational flexibility of the SARS-CoV main proteinase (Mpro) dimer: molecular dynamics simulations and multiple X-ray structure analyses","volume":"354","author":"Tan","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jpha.2020.04.008_bib50","series-title":"ADME Profiling in Drug Discovery and a New Path Paved on Silica","author":"Kr\u00fcger","year":"2019"},{"key":"10.1016\/j.jpha.2020.04.008_bib51","doi-asserted-by":"crossref","unstructured":"D.E. Pires, L.M. Kaminskas, D.B. Ascher, Prediction and Optimization of Pharmacokinetic and Toxicity Properties of the Ligand, Computational Drug Discovery and Design, Springer, 2018, pp. 271-284.","DOI":"10.1007\/978-1-4939-7756-7_14"},{"key":"10.1016\/j.jpha.2020.04.008_bib52","first-page":"315","article-title":"Strategies to address low drug solubility in discovery and development","volume":"65","author":"Williams","year":"2013"},{"key":"10.1016\/j.jpha.2020.04.008_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jpha.2020.04.008_bib54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acs.jmedchem.6b01634","article-title":"Design and synthesis of a pan-Janus kinase inhibitor clinical candidate (PF-06263276) suitable for inhaled and topical delivery for the treatment of inflammatory diseases of the lungs and skin","volume":"60","author":"Jones","year":"2017","journal-title":"J.\u00a0Med. Chem."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177920303865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177920303865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:32:01Z","timestamp":1761859921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177920303865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2095177920303865"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2020.04.008","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202003.0085.v1","asserted-by":"object"}]},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2020.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Xi'an Jiaotong University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}